This Week in Startups · · Transcript & summary by WhipScribe
Working venture investors compare notes on AI-written founder materials, deal scoring and SPV fees, with concrete figures for each.
Tap a chapter to play it from that moment in the show's own player; the transcript opens there too.
“I want to be your first call on your worst day.” Ben · at 23:14 — ▶ hear it from here
“We're scoring the founder's domain expertise.” Ben · at 15:17 — ▶ hear it from here
Jenny Fielding of Everywhere Ventures, D.A. Wallach and Ben trade notes on how early-stage investing is changing. Everywhere has backed about 300 companies with pre-seed checks, and the panel agrees that many promising startups pivot, sometimes completely, as foundation-model progress keeps shifting the ground. Founders are now sending VCs company.md files that an AI can read in place of a deck, and Everywhere has reworked its own website so AI agents can find it.
The conversation then turns to judgment. Ben's firm scores deals on a one-to-nine scale and has found that its AI tools produce strong analysis but mostly middling scores, which he reads as weak conviction. The hosts argue that resilience, meaning how founders handle challenge, is the hardest trait to game, and that the human role of being a founder's first call on their worst day is unlikely to disappear. Fund economics follow: LPs chasing late-stage deals through SPVs, a shrinking number of emerging managers, and fee stacks that some sponsors charge.
The panel finishes with products and AI hype. Everywhere built an in-house data tool called Jelly after estimating that PitchBook costs about $20,000 a seat, and it plans to sell the product. They weigh whether cheap AI clones of Slack can undermine incumbents, and whether Anthropic's claims about curing disease within a decade are credible; D.A. puts his own odds between 1% and 5%. The episode closes with picks, including an implant that lets amputees control a robotic limb.
Jenny Fielding is co-founder and managing partner of Everywhere Ventures, an early-stage pre-seed fund that writes first checks. She has been a regular on This Week in Startups.
D.A. Wallach is a biotech investor at TimeBioVentures who joins the This Week in Startups venture roundtable as a regular panelist.
Jenny Fielding described Everywhere Ventures as an early-stage pre-seed fund that puts money in first, often in rounds of about $1 million. She said the firm has invested in about 300 companies, which she called pretty active.
“And we invested in 300 companies, so pretty active.”Jenny Fielding · 0:43
D.A. Wallach said Phantom Neuro has built an implant that sits under the skin above the muscle in an amputee's limb and reads the nerve signals meant for the missing hand. He said Everywhere was a seed investor about three years ago, and that the first patients were implanted in a study in Australia a few months earlier.
“And thereby you can control a robotic prosthetic limb just by thinking about it.”D.A. Wallach · 1:14:36
D.A. Wallach pushed back on Anthropic's Dario saying cancer, Alzheimer's, heart disease and mental illness would be relics within less than a decade. He said he is skeptical of that timeline, and that he puts his own odds of it happening between 1% and 5%.
“I hate being put in the position of being a hater”D.A. Wallach · 1:03:02
Jenny Fielding said Everywhere Ventures built Jelly in-house because PitchBook costs about $20,000 a seat for a small emerging manager. She said the firm has started open-sourcing it, has a beta with about 1,000 people on the waitlist, and plans to sell the product.
“So we built some of this in-house and now we've started to, we call it Jelly.”Jenny Fielding · 29:33
D.A. Wallach argues that promises like curing all major diseases within a decade overstate what AI can do, and he says the frustration is that skeptics get called haters. He also argues that founders are now sending investors AI-readable company files, and that investors should keep their judgment about what they can actually check.
Jenny Fielding described Everywhere Ventures as an early-stage pre-seed fund that has invested in about 300 companies. She said it aims to be the first money in, and that its rounds are often about $1 million, sometimes just a group of angels. She argued that few funds still write early checks, so founders with deep-tech or unusual ideas need investors willing to back them before they have traction.
Ben said the statistic that family offices put 34% of VC commitments into SPVs, up from 9% in 2019, overstates the trend. He said a large share of that money went into OpenAI and Anthropic, two companies that together absorbed more venture money than any companies in history. He still expects more family offices to co-invest directly, because private AI names feel exclusive and sexy.
Ben said his firm scores deals on a one-to-nine scale, skipping five, and feeds them into AI agents. He said the AI's analysis and market mapping are high quality, but its recommendations come back with low conviction. Almost all scores land between three, four, six and seven, which he calls a weak-willed yes with reservations.
Jenny Fielding said PitchBook costs about $20,000 a seat for a small emerging manager, and about $15,000 more for API integration. Everywhere Ventures built Jelly in-house to avoid that cost, then began open-sourcing it and offering it to other managers. She said a beta announced the week before had about 1,000 people on the list, and the firm plans to sell it.
Ben said he is not afraid of an algorithm being a better picker of startups. He argued that AI still cannot build the trust and relationships at the heart of venture work, and said the role he likes is being a founder's first call on their worst day. He thinks founders who want that kind of camaraderie will keep choosing human investors.
D.A. Wallach said he is skeptical of Dario's claim that cancer, Alzheimer's, heart disease and mental illness will be relics of the past in less than a decade. He said cancer alone is hundreds of diseases, and that he finds it frustrating to sound like a hater when he has spent a decade working on healthcare. He put his own odds of that outcome between 1% and 5%, based partly on the view of top technologists.
D.A. Wallach said Phantom Neuro has developed an implant that sits under the skin above the muscle in an amputation stump. It detects the nerve signals meant for a missing hand or forearm, letting a patient control a robotic prosthetic limb by thinking about it. He said the first patients were implanted in a study in Australia a few months earlier, and that Everywhere was a seed investor about three years ago.
Our own transcript of the public episode, with a timestamp about every 90 seconds. Tap a timestamp to play the episode from there in the show's own player; the link button on a paragraph copies a link that opens this page there.
0:00All right, everybody, welcome back to This Week in Startups, our venture capital roundtable. We do it every Wednesday live. We ship it later that night on Wednesday, sometimes Thursday morning. Really excited for our panel. D.A. Wallach is back for the third week in a row, becoming my partner in crime here. He's from TimeBioVentures. You can check out more about them at TimeBioVentures.com. I'm an LP, and things are going well, DA. Thank you, Jason. This Week in Startups is brought to you by Stripe Startups. Stripe Startups offers early-stage, venture-backed startups access to Stripe fee credits, expert insights, and a focused community of builders. Apply today on stripe.com slash startups.
0:43Odoo, the all-in-one business platform. Your first app is free. Get started today at odoo.com slash twist. Superhuman. Superhuman Go is an AI chat that's always there when you need it, already aware of what you're doing, and doesn't ask you to start from zero. Sign up to get the best in AI at superhuman.com. This fund is going to do well. And I'm saving a slot for you in Launch 5 so we can round-trip our LP interest in each other. Jenny Fielding is here. She's been on the program many times. Everywhere Ventures co-founder and managing partner. Tell us a little bit about Everywhere Ventures. Yeah, early-stage pre-seed fund, investing across many health, and work. And we invested in 300 companies, so pretty active.
1:30That is active. I'm assuming pre-seed and seed, yeah? No seed, just first money in. And honestly, it's a rare breed these days. So you do it, Jason, and a couple other people. So you're trying to do what first round original value prop was, put the first 250K into the seed rounds and have conviction. In the pre-seed, yeah. So typically the rounds are a million dollars. Sometimes they're just a bunch of angels or a couple of microphones get together. But these are almost like angel rounds, but we're institutionalizing that. You know, it's very important that we have this in the market because everybody's a coward, Jenny. Everybody is like lemmings in our business, especially at the early stage. Oh,
2:13who's in? Who's leading? Yeah, let us know how the round develops is what a lot of VCs like to tell people. You tell them the opposite. Hey, this is a fit. We're putting the 250 in. We don't care who else is in or we're not in. Am I correct in summarizing candidly? Yeah. And especially, you know, in these days, if you think about, you know, some of the deep tech or the futuristic stuff, it seems like science experiments. And if we don't have people, you know, really at the earliest stages, like how are these founders going to come to be? Because most folks, they want to see a lot of traction. And the very famous Lear, the very famous Ben Lear of Lear Hippo, managing partner, you know them. And they did Warby Parker back in the day, Venmo back in the day, Zipline.
3:01Not sure when you got into that. We did the more recent last two rounds ourselves. First check, baby. First check. Many, many moons ago, I was just a boy. It's crazy because I met Keller and he pitched me that same round. I said, you're doing fixed wing drones on a slingshot in Africa to deliver blood. Hardware is hard. This technology doesn't work. I don't understand the consumer base. We invest in American companies operating in America. I would love to donate to this, but it doesn't feel like a venture investment. I don't know how I'd explain it to my LPs, but you had the courage of your conviction. We invested when it was a company building robots, toy robots for kids, pre-becoming a fixed wing blood delivery platform in Africa. So
3:55we were even stupider. Right. And that's the key lesson here, DA. It's a key lesson for all of us, better to be dumb and lucky than to actually try to figure out what great founders are capable of. You knew he was a great founder. You knew he was always very special. I'm sure you felt that when you talked to him. And I think that much like Jenny, we are also early stage focused and believe that you, you know, we're wrong more than we're right. But, you know, you do this long enough and you get a feel for when you're sitting across the table from someone who's nuts and maybe going to do things. Yes, that is a key to what we do as investors at the earliest stage. We're betting on a team. And I don't know, it feels like maybe half of my companies pivot in a significant
4:43way because we are preceded investors as well. That tracks, Jenny, for you too? 100%. In fact, like I wish there was more data around it. It's hard to get. But I'd say in our portfolio, at least a third and some of our biggest companies have pivoted. Yeah, it's basically the successful ones are the ones that pivot. Explain why you think this is, Ben. Well, I think actually, interestingly, I'm not, I'm not, I'm making this up as I go, but I think you may see even more of it now because the ground is just moving beneath our feet in ways that it only does during a real sort of reshuffling and, you know, revolutionary moment in technology. And, you know, with what the foundation models are doing
5:22and the spaces they go into and how they move, it's just not clear what the enduring models and moats are going to be. And so you bet on brilliant people early and they have a notion and they start building. And it turns out, you know, I would say that Zipline is an interesting one because hardware companies doing wholesale pivots is obviously very difficult. You sort of have to start truly from scratch, whereas software companies with the pace of development right now, you can do something for six months, decide it's not the thing. Cursor is like a pretty good example of this, right? I mean, we have lots of recent examples of things that ended up being very valuable very quickly and started as something else entirely.
6:02And I think you're going to see more of that. Yeah. DA, does this happen in bioscience and biotech? Well, yeah. Biotech is a little tough to pivot, right? For some of those same reasons that hardware is that maybe Ben was alluding to. And I think the reason for that is the fixed costs of taking things, particularly in the clinical trials are just extreme by comparison. And so once you start down a path, in particular, once you've selected the indication or the disease you want to go after, you're kind of locked in at least through that first human trial. And so we do see quite a bit less pivoting at the later stages, but we see a lot of exploration in the early stages as companies try to take
6:45a technology or even a specific molecule and figure out where they can apply it with the greatest impact. I always tell founders when we invest, keep your eyes in the peripheral vision. If you see something off to the side and you're interested, it's okay with me if you go explore it for a week or two weeks, you make an MVP because man, I see that happen all the time. Founders like, wait, there's something over there. Our best returning investment in our fourth fund, Micro One started, crazy founder, Ali, I knew would be successful at something in life, was just using AI to figure out who was the best developer, who's in the 0.1% of developers. And then he's like, yeah, and by the way, I have friends over at this large language model company,
7:28and they need data. So we took the developer data, we kind of packaged it up, and we sold it to them, and they want more data. So I think I'm going to try to build them a way to get data to put into LLMs. I mean, they're at a billion dollars in revenue right now. Wow. And we invested at a $12 million valuation. Crazy. That's awesome. I mean, a full-scale pivot. I'm going to take a moment before it gets too late to put on my Plod device. I'm going to hit record. And then I don't miss a moment here. Plod is an amazing hardware solution. You put a pin on it. You put it on the back of your computer. You record everything. It uses amazing software put it on the back of your computer, you record everything,
8:05uses amazing software to summarize it with hundreds of templates. And then you can connect it to all your AIs and do your to-do list, action items, all that great stuff. Check out plod at plod.ai slash twist. Use the promo code twist and they know we sent you and they'll give you 10% off. Not that you guys need it, but you can get that. Hey, DA. Yes. You know, you're very good at finding interesting stories. I think you're a curator amongst curators. Might come from- I saw something this morning in particular that I wanted to throw to this group. Yes. The managing partner founder of Dragonfly Ventures, smart guy, Hasim, or what is it how does he spell his name hasib koreshi hasib correct this tweet here hasib koreshi look at what he said he
8:53said founders are now sending them markdown files company.md files that they can open up with their LLM of choice and utilize to basically grok everything about the company. So rather than a pitch deck or a video or doing a phone call, you can just pull up that Markdown file and start asking it questions about the business. And I thought, wow, this is a new thing. I have not yet encountered this. And curious, Ben and Jenny, if either of you has. Yeah, I'll jump in here. So about a year ago at Everywhere, we have a full-time engineer on our team. We started thinking about how do we optimize a small VC so that we show up in all the searches and founders know about us. And so we did a little bit of research and we saw that actually almost no, it was like 99% of the websites that we looked
9:50at of other VC firms weren't optimized for the agentic world, meaning that they didn't have FAQs, they didn't have ghost pages. And basically agents couldn't discover it because the way that they described their firm wasn't agent friendly. So we were, I think, among the first to kind of do that. And we actually saw the results, which was pretty interesting of just how that was surfaced about us being a pre-seed fund and all that. So we kind of jumped in early. And I think that, you know, this was the second manifestation of it. If venture funds are going to do it, obviously startups are going to do it as well. And like, what a cool way to be able to prepare for a meeting before and kind of like self-serve as
10:30you're getting to know founders and industries without having to set up a call and do all these things. So I think this is the next evolution of, you know, agentic venture and I'm all for it. We talk about it every week on the pod. Startups have everyone using AI now, but a lot of users are still stuck in that chatbot zone, kind of using AI like it's faster search, but they aren't getting the kind of productivity boost that's possible when you give the models the right data and the right context. If this sounds like your company, it's time to check out Superhuman Go. From the makers of the amazing Grammarly with Superhuman Go, there's no need for endless copy and pasting of transcripts, moving over documents, writing prompts, or switching tabs. Your AI is already present
11:14and ready to help in every email, document, and spreadsheet. And it already knows enough about your company and your day-to-day tasks to provide real time-saving assistance and not just vague suggestions. Plus, Superhuman Go is proactive, helping you spot and prevent mistakes in your emails and documents before they go out to the real world. Give Superhuman a try for yourself at superhuman.com. That's superhuman.com. By the way, this seems just like a natural evolution. Everyone is clearly feeding all of these materials into some version of off the shelf or, you know, internally trained or whatever. Like everyone's got their own way that they're using AI to help them make decisions and help them get through work. And
12:00like, if you want to skip some steps and help us, fabulous. I don't know that we need it. I think we've, you know, built enough AI skills internally where we can, you know, ingest files that are not expressly built to be ingested and we're doing just fine. But I think I most agree with number three here and number four as being the thing that, like, I don't think you're saving me a lot of time um but like you're clearly expressing that you're leaning in that will be gone in like six weeks when everyone starts doing it because they know that it's a signal that says something but um i think the neutral read is actually really the key to it which like, you're going to be a company that is going to,
12:46you're comfortable trading on your merits and like what you really are versus some like weird manufactured, like, you know, don't look in that room story. And so like, I think this is a good thing. I don't think it's like changing the world, but I'm all for it. And Ben, there's an interesting thing that I know Josh Wolf has said in the past from Lux Capital, great investor, very successful firm. Josh has said their biggest success stories historically have been companies that were highly contested among the partners in the investment committee meetings. In other words, one or two people really wanted to do it and others absolutely hated it. And by contrast, the sort of consensus, yeah, this is an obvious bet ones have disappointed, relatively
13:32speaking. Now, if we're all going to be feeding presentation materials into our AI and respecting to some extent its opinion. I'm curious for you guys, like how far are you willing to go against the AI? Are you at a point where you've fed stuff in and it said, this is a terrible investment, never do it. Are you ever gonna supersede it? So two things. One is we've all heard that adage about the contested deals or the great deals. I think Sequoia has also talked a lot about this in the past. If that's the case, then we should be concerned about this vintage for late stage companies because the companies that are getting access to the real late stage capital are all these like highly, highly consensus deals. Now I can't speak to what actually happens in the partner meetings
14:28of these mega funds, but right now we're operating in a market where there's this belief that every, that like things are obvious. And so that's just like an interesting little tidbit around the edges of that. As far as the advice AI gives, we get really great analysis and good market mapping and good work. We actually find that the recommendations from AI are, no matter what we do, really disappointingly low conviction. And so we have a scoring system that we sort of play with internally where we like to score deals on a one through nine, no fives. And one through nine, no fives because cowards pick fives. I do one through 10, no eights because cowards pick eight. Normally it's a world of no sevens, but we could talk about this separately, Jason.
15:17But I do think that there is, so we go and we put it in and we get scores between three, four, six, and seven, almost 100% of the time, which is just like a pretty weak-willed, you know, it's like a yes, but with reservations or no, but we could flip it if. And so I find the work to be very high quality. I find the actual answers to be not even particularly relevant at all. What are the variables? Give us a little hint. Don't give us the whole algorithm. I know it's proprietary. No, no, no. Do you have some variables? Because I'll give up a couple of variables for us. We have actually a number of variables that I couldn't even... We're scoring the founder's domain expertise. We're scoring the founder's willingness to be,
16:09like how they deal with being challenged in the meeting. We score the quality. Wait, let's unpack that one. Do you want somebody who is brash or do you want somebody who listens thoughtfully and answers the question or both of those things? What do you want? We continue to play with these and have multiple agents running that treat these a little bit differently. I mean, this is an imperfect world where we're screwing with this possibly. I think the idea is you want, I mean, I guess the like cliche is, you know, strong convictions loosely held or whatever, but you want people who can, you can have real challenging conversations with who address those challenges head on, who don't skirt the subject, who are willing to acknowledge
16:51what they don't know. I think that like, I don't know that we have a different formula than anybody else in terms of talking to somebody who feels substantive and who feels, you know, at the same time, passionate and not so insane and stubborn that like, we're never going to be able to work with them because they have no interest in hearing anyone else's voice. Yeah. But, and, and it's a, it's a bunch of these things that we score all at once to try to come out with some overall, uh, metric. And then of course we also plug it into our fund model and how many positions we try to get. And it's gone back and studied all of our prior funds and where we find fund returners to try to pull out, not just,
17:30is this a good deal, but does the math or the ownership work for all? This is a key one, DA and Jenny. I have become cutthroat in my later years with the team who are like, this is a great thing. And there's a hundred K available at this $20 million valuation. I'm like, so we own 50 basis points, do the math. It's a, that's a $45 million fund. What does the outcome need to be for us? If we get diluted 50% along the way, what does the outcome need to be? And it's like, oh, it has to be Uber. It has to be $140 billion. And I'm like, okay, not too many of those. So let's move on to the next deal and stay in touch with this founder. And they're like, oh, but can we put it in a little? move on to the next deal and stay in touch with this founder.
18:05And they're like, oh, but can we put in a little? I'm like, if we put in a little, then I have to go back to the LPs and explain why we did this bet and didn't put in a lot. And it was a waste of our time because then we put the same amount of work into every founder, the same amount of work into every founder, whether it can be a fund returner or not. So you really need to keep that sort of discipline in mind. I like the signal here. I don't like giving too much of my playbook away, Jenny. You know why? Because then people game it because they listen to the pods and they're like, ask their agents, hey, how can I get through J. Kyle's screening process? How can I get Sequoia's payment process? And that's what I realized when I started this podcast over 15 years ago, is every time I explain this stuff, six months later, it would be
18:49incorporated into people's pitches. And the gamesmanship became crazy. Now I just look for the indefatigable, indefatigable, how do you pronounce that word? That's what I was going to say. I think that- I need those founders. The number one thing we look for is resilience. And how do you game resilience? Right. That's through a series of interactions. And I mean, you can call them tests, but it's really about how that person responds. Right. And I think to Ben's point, right. You know, the challenges, the chip on the shoulder, these are all things that you evaluate. So I think resilience is a hard one to gain. I just gave everybody on the team. J. Cal, right, you don't respond to the first 30 emails.
19:31Right. I wait for 31 now. Because you just want to make sure they've got that hustle. We can't, on the one hand, be perpetuating this story that AI is going to solve everything, going to solve incredibly hard problems in the physical sciences, in biotech, in finance, and at the same time believe that it's not going to be capable of rigorously evaluating companies and ultimately giving us a score other than four or five or six. I mean, why do you guys, I mean, do you believe, and if so, why do you believe that we should have jobs past six months from now or a year from now? Because it seems like what we do as an analytical and risk-taking endeavor should not be beyond the reach of these AI projects if they really can fulfill the capacities that they are promised.
20:34I have the answer. Remember Chamath started capital as a service, put in all your SaaS metrics. We tell you if you're funded, we just give you the funding based on your metrics. Yeah. And if in music, you'd be like, well, this is a banger. It's got a great hook. And I like the solo here. If it was that easy, then it would be science. And then on the other side, you have art. And I always tell people what we do is alchemy. It's some mystery in between those two things that takes a bit of instinct. And then once you're on the cap table, are you relentlessly supporting the founder and being the guide on the side, the, you know, warm ear who gives them encouragement depending on what they need or help some problem
21:16solve. So I think that function of just being a human who is enthusiastically on the cap table, rooting for you, like if you can get really five or 10 really great humans on your cap table who are like, yeah, we can do this. This is instrumental. You can do this. How can we be helpful? I feel like that part of the job is the most human. But the analyst part, you're probably right. Look, I agree with you. As we all know, there's the pick in them and there's the work in them. And I agree with you. The work in them is irretrievably human. It's gotrievably- I do think the analyst- Yeah, you're right. The analysis should be, you should be able to get great analysis that's better than most of the people on your team.
21:53But then maybe the conversation on top of that analysis then becomes the higher order bid. Hey, my algorithm says this, your algorithm says that in the partner meeting, right? Odoo is the all-in-one management software that brings together everything you need in one easy-to-use platform. It's a simple solution for founders. It's going to save you a lot of time, but that's easy enough for me to say. Let's actually dig into one of the real apps you get access to when you sign up for Odoo. Odoo Purchase. This is where Odoo brings together all of your suppliers, price lists, purchase orders, and vendor performance stats into one simple dashboard. No more realizing you're out of stock after a customer places an order
22:30or digging through old Slack threads to try to find a price that you set last quarter. No, Odoo is going to help you automate everything like requesting quotes from suppliers based on your current stock levels, then generating the invoice without you needing to reenter the numbers. So if you're still cobbling together a back office across five different apps, it's time to check out Odoo at odoo.com slash twist. And if you sign up today, your first app is free. That's odoo.com slash twist. When we think about how we're using AI internally, it is in service of protecting the like real atomic unit of value, which for us is a minute spent face to face with the founder, building a real trusted relationship.
23:14And so how do we automate away all the rest of our job in order to actually make those human relationships matter and productive. And look, there is some very grim future where founders would prefer an algorithm to be their investor in some way, I guess. But, and by the way, I'm not afraid of the algorithm being a better picker. I actually embrace the idea that the algorithm is a better picker. I still don't think the algorithm is going to be able to build the relationships and build the trust. And, you know, I like to, the role that I like to fill, even though it's a little bit, it can be painful is I want to be your first call on your worst day. And I don't think that AI is ever going to replace that. And I think that
24:06not every founder wants it, but the founders that do will, you know, are going to pick an investor that they want to have that sort of camaraderie with. Yeah. I don't think venture capitalists are a profession of the future. Like, I don't think that this job will really exist. But I do think, you know, to Ben's point, and yours, Jason, like the cheerleader, the coach, the psychiatrist when you need one. I think these are things that are, you know, very basic to humanity, kind of going back to DA's original topic. And I'm not sure those are going to go away. But I do think our job is going to change. That's very interesting to me because I totally agree with your points about these services that are provided by really great investors like the three of you.
24:58I won't include myself in that. I don't believe in services. I think that's all total BS. Oh, I don't either. I mean the service. I don't believe in services. I think that's all total BS. And I see on Twitter and LinkedIn and all these founders saying like, you know, I want my investor to help me with introductions and products and all this stuff. And like, no, you just literally at the early stage, at like the precedence seed, you need someone that's not going to be destructive and who's going to be your total um cheerleader i think that's so i i'm talking about the service that that ben mentioned which is being your first call on the worst day you know serving a governance function as things
25:31go further along and you need to make tough decisions navigate the capital market you could argue though that all of those very human services i mean for lack of a better term or or value ads that vcs bring to the table meat based-based. They're meat-based, DA. These meat services are arguably highly overpaid by founders of successful companies. I mean, it's not unheard of for that early investor who's getting the first call on the worst day to make over a billion dollars if the company goes really well. And you can go hire the greatest performance coach in the world for much less than that. So if we do it just sort of fast forward. But that person also puts their reputation on the line. I think it's a good challenge, DA. But that person puts their reputation on the line and gives up decades of their lives to match capital with talent. And that is a very unique
26:34position in the world and is well worth the 20% or 25% that LPs pay for it. And it's well worth the 20%, 30%, 40% of the company that winds up being given to those LPs and that little sliver of carry that people make it until such time as there's another funding source that does it better, that balances the LP need to deal with chaos. I mean, if you really think of what we do, LPs do not want to go into the muck and the chaotic nature of years one through five of these companies. If they did and they had to deal with the BS we have to deal with on the margins and the chaos and the fraud and the insanity, they would they they're like, yeah, that's way too gnarly for me. It's kind of like people who invest in movies or movie studios. There's like,
27:26there's some studio head and Bob Iger says, it's all going to be okay. Well, I read in the paper that this, you know, this director just beat somebody up on set, did this crazy. Nope, it's fine. We got 10 movies. This one gets delayed. It's okay. It's all going to work out in the wash. I think that like plays a role in society. And then you would ask the same question, DA, what's the point of these CEOs? What's the point of these founders? Like, can't we just put everything on autopilot and let somebody just, and I got pitched by a VC, very well known, said, I want you to invest in this company. I said, okay, now you're the founder. He says, the founder is my partner. I said, what? He said,
28:02the founder vibe coded a startup and we're just building it in-house. So that was my first example of a VC finding a market, going after it doggedly and just writing the code themselves and being like, we don't have a founder for this. So we're just going to have one of the GPs be the founder. Well, I think, I mean, this, look. Well, this is the next topic. I'm going to tell you about the company that we're spinning out of everywhere. Oh, what? Okay. It's a segue. I'll allow it. We'll call an audible here. Jenny, over to you. Well, it was such a good intro. And by the way, it wasn't you who did this. No, I know. I know, but I'm not asking anyone to invest. I think the guys are going to maybe pull up a visual, but.
28:47Okay, here we go. All right. So as a early stage investor, a pre-seed investor, what do I spend most of my time doing with 300 portfolio companies? Making introductions to later stage capital, helping my startups, you know, research who, you know, should, you know, who would be good investors, et cetera. So we spend so much time trying to do this. We actually put together a little platform. We built it in-house for ourselves. And then some of our friends wanted this. And basically, we have to beg, borrow, and steal to get this data. As a small emerging manager, PitchBook is about $20,000 a seat. And wow, if you want the API integration, throw in another 15K. Then layer on things like Harmonic. I mean, these are all great products, but it gets
29:33to be quite expensive. So we built some of this in-house and now we've started to, we call it Jelly. And we've started open sourcing it and actually, you know, providing it to other managers and potentially selling it. So we have a beta. We announced it last week. We had got a thousand people on the list. And it gives you some of the things that PitchBook doesn't give you, like insights into what investors are talking about and thinking. Just if you look at this screen right here, you know, what is Jason talking about on Twitter? What's important to him? So as a founder, if you go pitch him, if you want to get in touch with launch, you kind of know what's relevant. So we tried to synthesize things that we thought were relevant for us and our
30:14peers. So this is our first attempt at everywhere as a venture fund to spin out a product. We are not raising money externally or hitting up, you know, our friends for money, but we will be selling this product soon. We're having a ton of fun. Obviously, us, everyone, it sounds like, yeah, we're going to sell it. I mean, $20,000 versus, I don't know, you guys can tell me how much we should charge, like $50 a month, $30 a month? We're taking some input. Yeah, this is a very interesting moment in time. I don't know if you saw a similar thing, Ben, but let me replace this one. My friend, Kevin Rose, who did Dig many years ago, decided I would like to have a better version of Slack. And he started building it and he just gave it for free to the world on GitHub.
31:09And I said, how long did this take? He said, four to five hours a day for about a month. And I was like, hmm. And I said, how long did it take with Fable 2.0? Obviously, the answer is half as much. But I talked to him. I was like, are you going to make this into a company? Because I kind of like the idea. At the same time, Jack from Square launched his own version of Slack for developers. So Ben, what does this say about the future of incubation of ideas and startups and technology? Okay. There's so much exciting innovation happening every day in AI, and so many companies are just shipping all these amazing new tools. But, hey, these AI startups pose several specific challenges. They require a lot of flexibility and an infrastructure that can scale up fast.
31:58Thankfully, Stripe Startups is here to help. Yes, our good friends over at Stripe are offering early stage venture-backed startups access to a whole suite of perks, Stripe fee credits, insights, and mentorship from experts in your field, tools that help you reduce decision fatigue and stay focused, and membership in an active community of real builders. More than three out of four startups in Forbes' AI50 are already using Stripe for payments, billing, invoicing, and taxes, giving you an overall view of your revenue so you can make smarter, more informed decisions. Learn more and apply for the program today by visiting stripe.com slash startups. That's stripe.com slash startups. Stripe Treasury includes various distinct Stripe products.
32:41See stripe.com slash legal slash SSA. Stripe is not a bank. Checking accounts are provided exclusively by Fifth Third Bank, National Association member FDIC. Well, I think it says more than just incubation. It says something about more than just incubation. I think this is the great challenge of the market right now is somebody can go and build something that feels like it is in some way, shape, or form a feature parody with Slack on nights and weekends. Now, I would say sort of a few things. One is obviously the sort of network effect and the distribution remains this important thing. The, you know, and the distribution providing a user base that then creates a data advantage. And so without a distribution or a data advantage,
33:28you know, you're really just vibe coding. I think there's another layer to this, which is the hardening of that system and building it so that it can really truly support the sort of nuanced needs and the security concerns and the SOC 2 compliance and all the things that you need to build to go around a product that's actually enterprise ready is I think people like understate that, I can go vibe code this thing quickly and actually building something that truly does what Slack does is not, like Kevin did not build that yet, but I'm sure he built something that's good enough for plenty of people. And look, the reality is this is the great challenge of this space right now. And I think it's one of the reasons that you see the late stage consolidate around companies that appear to have cracked the distribution and data moat because they go, it's going to be hard to compete with this.
34:17And I'm really and I don't want to make a bet on this other new team, maybe figuring it out when there's going to be 40 teams or a hundred teams or a thousand teams that can all go build the same thing. And so this is why instinct, like instinct has gotten into the zeitgeist and has the user pull. And as a result is now worth 30 billion. It doesn't matter what you think it's worth. Like is now to someone. Is it worth $30 billion? To somebody it's worth $30 billion. To somebody it's worth $30 billion. And, and I think that that is, uh, like, you know, you fall or you do fall into the too big to fail category or whatever it is. Even while Kevin goes and builds that Slack continues to perform exquisitely well, is probably the best buy that Salesforce
35:05has ever made. And so the SaaSpocalypse of it all hasn't happened yet. Is it going to happen in some categories? It may, but Slack also knows what AI is. And you'll probably use some of it. But don't you think it's cool to be able to serve niche communities? And I think that's what we're trying to do. We're not building this for all of private equity. We built Jelly for our peers, for people in venture capital, specifically who can't pay for this. And I feel like Kevin probably the same. He's not trying necessarily to kill Slack. He's trying to provide something for the people that need something like this who are his peers, right? So I think the you know, the vibe coding and I agree, you know, the security levels aren't there, but how exciting that we can all,
35:51you know, serve like specific needs as opposed to generalized software of these niche communities. Yeah. But Jenny, what happens if you sell a thousand seats for $600 a year and you're sitting there and you're like, huh, and you have 20 more feature ideas and you have four people working on this, you're going to want to add a zero, right? You're going to want to add a zero. And I think that's the danger for the incumbents is that people are going to come to this. And there was that famous expression, your margins are opportunity DA. Like, yeah, I'm kind of looking at this going, well, if everything, you know, becomes free and then people basically they're restarting the game of Slack, they're restarting the game of
36:31Figma and design. It's like, you know what? I can put something out there that my peers use. I get 1% market share and let's start the game over. Right. Well, I just think it's an embodiment of the century-long trend of personalization in every industry. And to Jenny's point, she can make a version of a data platform that is really narrowcast to the needs of venture capitalists that she knows as well as any of her peers or prospective customers. And then for us on the other side of the Zoom, the question becomes, is she trying to charge us more than would lead us to just build it ourselves, right? I mean, because that's now the new game that everyone is playing is someone comes to you and says, look, I've taken a month
37:25for four hours a day to build this thing. And it's basically like, do you, do you too want to spend four hours a day for the next month? Or would you rather just give me $20 a month? And right. I mean, so it's a great hours a day for a month. I'm trying. It's all about pricing. I literally, you took the word out of my mouth, DA. Ben, is this literally just we're going to have to rethink pricing of products? If a version of Slack can be made and be offered at a flat rate instead of per seat, and then some startups are like, yeah, I want to save that money. It's kind of like free cap table software. We announced a deal yesterday in a category where there's going to be multiple players. It's an AI
38:08first law firm where you pay for the work, not for the time. Oh, give it a shout out. It's called Black Letter. Okay. They're, you know, sort of Crosby was the first mover. We think that this is a fascinating team at a co here that we think is going to do this in a really wonderful way and is building the best technology in the space. I don't need to give too much of a- Valuation $12 billion. They have three people with $12 billion. At least, at least. I mean, you know. And your price matters. But this is an example of a model where you rethink the model of an industry that's been around forever. We paid for people's time. Now we pay for the work. You want to go get a series? Be done. I'm going to
38:48charge you this much regardless of what, you know, I can guarantee you a quality product with a fixed price. People would prefer that. People would- So disruptive. And look, I think one of the reasons that you have seen this move in the early stage that I'm sure everyone here who invests is seeing, which is this preference for younger founders, younger and younger and younger and younger founders, because there is now such an emphasis on speed. And the idea being if, as you said, DA, it's like, well, you know, maybe I just want to go build this thing that Jenny's building. If Jenny wants to charge me 20 and I can do it for 19, what's the point? I'll just build it myself. I think now we are favoring teams that we think are going to move
39:33faster and faster and faster and faster and be more and more AI pilled and have more like fleets of agents deployed and, and cover more ground more quickly because that is the advantage that like the advantage is that the moats are smaller and so we we favor teams that are going to move faster and younger people tend to have less distractions in their life and need to sleep less and use more ai and all the things uh all right let's's talk SPVs. SPVs versus funds. I think, Jenny, you found this one? I did. So I'll tee it up for everybody here. And then part of being a great panelist is to pick the person you want to pass it to. So. Okay. Well, I think both of these guys are having a great perspective on this. So family offices put 34% of VC commitments into SPVs, up from 9% in 2019.
40:34So in other words, instead of putting money necessarily into their funds, we can extrapolate, they put that money into single purpose vehicles, which was kind of interesting. So I saw this on Twitter, Breezer Clarkson. So she's an LP. She was at Sapphire for many years and has invested in many funds. She has a fund of funds. And she's very active in kind of talking about the inside baseball of what's happening on the LP front. She's great. You should go follow her. So she asked if the fundraising slowdown, which we're all experiencing and seeing, is capital leaving venture, basically just saying, you know, it's an underperforming asset or, you know, we're going to put our money elsewhere, or just changing how it's invested, meaning into these single purpose vehicles where the LPs are
41:24investing directly into individual deals as opposed to spreading it into a fund. So super interesting. And the thread argues that limited distributions, you know, by LPs towards, you know, picking individual companies instead of making, you know, another 10 year fund commitment is kind of the trend of the market. So I looked in my own LP base, and we do have, you know, a number of family offices. And I would say this does actually track for us where our LPs are even more interested in our later stage deals, right? So these deals are more de-risked, and, you know, less interested in, you interested in putting money directly into funds. And so we felt that as a small manager, where they've kind of rebalanced where they're putting
42:12their money. And I think other emerging managers are feeling it as well. So I'd love to hear from Ben, actually, because I imagine when you started all those years ago, your fund, it was smaller and you had kind of maybe less institutions and kind of smaller folks. And if you've seen anything like this. Yeah. So first of all, I think like the misleading thing about this is the percentage of that money that went into SPVs and open AI and Anthropic is enormous. And so this is not, this overstates that trend because you have two companies that in four years consumed more venture money than any companies in the history of humanity. And so these are like, that's one. And so I think it's really important to note that like,
43:02I don't think, by the way, I think this is a real trend. I just think that, like, it's a little misleading when you have two companies. Usually the biggest and best companies don't just need constant infusions of tens and tens and tens of billions of dollars. But either way, doesn't that mean that that's less money going into those emerging managers? Whatever the reason. Maybe or maybe not. Because it's a percentage, it could be, Ben, that they're doing both and that this is like replacing something else in their portfolio. Maybe it's replacing some real estate investing. They're like, I'd rather move some real estate money over here. No, no, no. But I think Jenny's right. People want more co-invest, particularly right now when we have this fever pitch national story about AI and companies that
43:45frankly, the average investor should not have any familiarity with it or like an instinct is something that is like now a household name product for the people that run these family offices because it's national news. You have people chasing into these like into cognition or into these companies where there's just so much private demand. We just did this, you know, this new zip line round, like people coming out of the woodwork who want access to this company because it's this big, sexy thing that feels inaccessible. And all this money has been made in the private markets. And it's I think when we see, you know, the bubble deflate or burst or whatever, not that I don't believe that AI is like literally the best thing since sliced bread. I do.
44:32But like clearly some of this behavior, some of this stuff's going to work and some of it's not. Once we get to the point where some of it doesn't, you may lose a little enthusiasm around this. That's one side. The other side though, Jenny, is exactly what you said, which is there has been very little liquidity. People are like this is an asset class where at least in the last it underperformed for a few years relative to other asset classes. And in the last few years, the place where you've seen the great paper gains are at the very late stage. And so I don't fundamentally believe that that is the best place to invest. And my strategy would sort of like, you know, that's marketing for me, but it's also what I believe in, which is early stage investing. But I think that there is right
45:17now money is chasing into these things that have been compounding really quickly on paper. And they look like they're the closest things to liquidity. And I totally understand why there's that drive. And I think that you will see more and more family offices want to do co-invest and do direct because it's the sexy part and it feels like you get to play venture capitalist. I also think that good funds are going to be around. D.A.? I mean, I would, before I go to DA, I mean, I would just, if you scroll down, there's another chart that says emerging managers closing a fund. And so in 2022, there were 927. In 2025, there were 448. And then 2026 through Q3, 211. Now you can argue there were too many funds
46:03and this is a correction and all of that, but it also indicates that it's less money. And I can say as an emerging manager and all of my peers, it's been hard. And you're going to see a decimation of a huge cohort of emerging managers that we're not able to raise. So I think this also shows. It's great, Jenny, for us. Nothing would be more pleasing for that 927 number to go to 50, just straight to 50. You're a monster. There's 50 of us. We're all in it for life. We are all the true believers, Ben. We're not Johnny come lately's, Jane come lately's who think, oh, I can just raise a fund because this celebrity, you know, social influencer was able to raise one. I'm so glad to flush the tourists out, all the tourists
46:54out enough of being in my city. This is like being an Islander, Ben, you know, you live in Manhattan and then all of a sudden it becomes popular and it's like, oh, Nick's tickets get too hard and trying to get your, you know, reservation at your local place gets too hard. I love it. I'm like an islander in Hawaii. You guys can come for Christmas, but get the hell out come January 1st. We want the island back. Everybody out of here. This is happening in Niseko. It's happening in Tahoe. Everywhere I want to go skiing, it's happening. But I think it's really the, there is something going on here because our own LPs are asking us to get them into late stage deals. So what we did was we built two groups in the firm. We got a late stage group. We got the early stage. We do the
47:38early stage and then we do SPVs. We did vast space, you know, in terms of billion dollar valuation companies. We did vast space. We did Adams, Travis's new know, in terms of billion dollar valuation companies. We did Vast Space. We did Adams, Travis's new company, which came out of Cloud Kitchens, which we were investors in previously. We did Zipline. And we keep doing those deals as well. And it's really interesting. When we do a syndicate for an early stage company, it's 500K to 3 million. When we do it for one of these later stage, it's like 5 million or 10 million. We charge a 2% origination fee, like a sourcing fee, and that's it, one time. And then we take 20% carry. So I'm actually able, if we can put 100 million through this a year,
48:21to have $2 million to pay for a team and actually make it work and my LPs want it. Now what's happening is I get on the phone. I had a call with a family office, very famous one. I explained to them strategy. And I don't think they were a candidate for Launch Fund 5, like early stage, waiting 12 years for the fund to wrap up or 15. And they were like, you know, we really like your strategy. We think we also want to be in the fund. So we kind of brought them into the showroom with the Corvette, you know, and then we brought them in with, you know, Roadster 2.0. But they were like, you know what, I'll take that Model YL too as my daily driver. So I think most smart funds are going to figure out how to do both of these.
49:00When you have a hit, Jenny or DA, you're going to want to pop up an SPV. If you do, and you don't want to do the work, happy to split the carry with you and syndicate it to my syndicate. We talked about last week, the new industry that I call freelance investment banking, which is people who maybe would have been raising those funds, right? The 927, some of those people who don't have a new emerging fund have just transitioned to the SPV business. And that's all they do is go around and try to broker these deals. I think the challenge, Ben spoke to it a little bit, is that there's a perception that these late stage private deals only go up and that they all work. And of course, that's not going to be the case in the final judgment. So I think it
49:47is important for LPs who are even listening to this pod that they have the right comparator when they think about these things. When you're looking at a $8 billion private company raising a Series C through an SPV, you should be comparing that to public comps. You shouldn't be thinking about that as an alternative to doing an early stage venture fund investment. The dispersion in the outcomes is going to be radically different. The valuations are radically different and the risk reward is very different. So I think there's this sort of interesting convergence of incentives here where for the freelance investment banker who would have been an emerging fund manager, this is a very easy way to clip fees without cross-collateralizing
50:33your investing. In other words, you don't need to be good at investing because every deal is its own bet and they have nothing to bear on each other. And you don't have to, Ben, put in your, here's my first four funds performance. That's right. Yeah, here's our first deal. And then for the guy at the family office or the girl at the family office, although it's unfortunately mainly guys, who want to take, you know, the executive who wants to take a shot at one of these things, it's kind of a perfect product because they get to go and tell their principal and go to dinner parties and talk about this really innovative company instinct that they're, you know, it's cocktail party stuff, but it's not actually perceived as venture risk taking.
51:15So you don't need to put your career on the line as the analyst in the family office. Such a good analysis. But it gets to look like you're innovative. Let's get Ben and then Jenny. Yeah. I mean, you were clapping. You gave a gawp clap. I saw it. No, I agree. I mean, it's just, you shouldn't think of these, by the way, I would say the same thing about LPs who talk about investing in Andreessen's new fund as the same thing as investing in, you know, the same asset classes investing in the next LH fund. Like we both fit into venture capital in some like gigantic, you know, the same asset classes investing in the next LH fund. Like we both fit into venture capital in some like gigantic, you know, very broad sense, but like we're not in the same business.
51:50We need different kinds of outcomes. We, our funds are constructed differently. We're just like, it's because we both work in venture capital does not mean that like for an LP, we should serve the same purpose. And we've seen the barbell. The barbell exists in venture more than ever before, right? And I think you've, to Jenny's point before, not just using fewer emerging managers, I believe you will have less money raised by sub $500 million funds this year than in any year in the last decade. And so it's not just emerging, it's small funds are right now getting smaller, getting forgotten largely. And everyone is plowing into these mega, platforms. And in the short term, they've had unbelievable on paper
52:38performance because they're just like- They're putting big dollars to work. They're putting massive dollars to work. And some of these may be generated. Some of this might like, like they've been the ones that at least on paper are right. The last two or three years. And so even LPs that have always, that are like long-term professional LPs that have only been early stage focused and never wanted to do big funds are now going, maybe we should do some big funds. Um, at the same time, I think there's a little thing happening where folks who are in four or five or six platforms are going, you know, I'm actually going to cut some of these because they're in all the same companies. And I now have
53:13six exposures to blank and I really don't need six. And you're 2%. I mean, it's regression to the mean. You're just going to do the average very quickly. And the average inventor is not pretty. And so they're going to move away. And I think you're going to continue to see a real market exist at the early, early stage. And a real market exists in the megafund space. And the megafund space is going to take up almost all the capital. But there's still enough for great managers early. The middle is cooked. By the way, that is so not a innovative thought that the middle is cooked. The middle is cooked. The middle is cooked, of course. And they have no rights, right, Jenny? You have to, as an early stage fund, you have to write that side letter. You have to demand information rights,
54:01a board observercy, whatever it is. And of course, pro rata, or don't do the deal. And then when they try to erase your pro rata and later deals, you have to put your foot down and say, this is a contractual right that we have. We're not giving it up. And you really need to lock those things in. And I have had, you know, I'm now up to maybe a dozen discussions around people trying to wipe our pro rata out. I have won 11 of 12, 11 of 12. And then even in that 12th one, we didn't get it on one round. We got it on the next because they were like, well, it's convertible. So technically you don't have it. And then I just told the founder, technically, I don't need to be an investor in your company. So why don't you just
54:40buy my shares and I'll go and focus on other companies. And he's like, yeah, well, I kind of need you to retweet stuff and introduce me to influential people. And I want to come on your podcast. And I was like, well, then why are you telling your lawyers to screw me? He's like, the lawyers told me to screw you, Jason. And I'm like, the lawyers work for you. Who pays the bill for the lawyers? He's like, I do. Don't get me started on the pro rata. But I was just going to say on the SPVs, like the evolution that I've seen, especially for small funds, but, you know, maybe Ben can chime in on larger funds. It was always the case that as our companies, you know, got bigger and bigger, we had, you know, the inside insights. And so we were able to give an informed recommendation, I'd say,
55:21to our LPs, right, where we could say we're doing an SPV or you want an allocation, even if you want a direct one. And here's what we think of the company. And I think the evolution that we see and we've seen it at everywhere where LPs are coming to us and they're saying, I know that you're not an early investor in X company, but can you get us allocation? And so like we can oftentimes because we're, you know, well networked and we've got, you know, a lot of access, but we can't really give that recommendation whether that is a good company or not. So the thing that, you know, worries me is, you know, all of a sudden the LPs are becoming pickers. That's not primarily what they're set up to do.
55:59And they're, you know, have to do their own diligence, but we're somehow attached to it. So if that deal doesn't go well, it wasn't one of our portfolio companies, but we were kind of doing them a favor. So I'm seeing that evolution where fund managers, including ourselves, are now doing SPVs on deals that are not portfolio companies. And I think that's like a distinction that we've only seen maybe in the last, you know, couple of months, year. The way I explained it, DA, to our LPs is, hey, we missed Zipline. We knew the founder was great. We maintained a relationship with him. He came on This Week in Startups twice in the past three years. He's awesome. I invited him to come to the All-In Summit, yada, yada. And he gave us an allocation. So we made a mistake. We missed it early, but we got it late. And they're like, this is great. And I have now started to craft my early stage product. And you can crib
56:45this, Jenny, if you like, as, hey, we're going to get great returns. Look at our track record. But we're also going to be an early warning system for you. Look at what's breaking out in our portfolio. Talk to our team anytime you want. Call us up. Ask us about companies. And we'll be able to introduce you to the founder and give you that early signal. So if you think about it like a data product that you just built, if they were in all four of our funds at the early stage, then they get all that data. That could be an important signal for them when they're actually making those later stage decisions on different categories. It's definitely an interesting time to be alive. And the other thing that's going to happen with SPVs,
57:27you're going to see this in the next year or two, is a lot of lawsuits, a lot of lawsuits. People were doing off-book stuff, illegal stuff, unethical stuff. And then some people are charging 3%, 2% or 3% per year in origination fees every year. So you put money into this company at $30 billion, $40 billion, and you're paying 3% on the $5 million you put in every year. So when I said it's 2%, one of the family members said, per year? And I said, no, no, one time. They said, oh, OK, because we're paying 3% with this one for the next 5, 10 years. And I'm like, so you're paying 20 percent in fees 15 20 percent if it gets distributed in the next five years you say yeah i said how does that make sense like yeah we asked ourselves that same question but we yolo but yolo totally but like
58:14it's we needed to be in this thing yeah and then i talked to one of these guys who's doing it he's like yeah it's the greatest business ever nobody questions it and uh you know i'm now making x millions in fees every year and I don't have to do any more. And people don't know if they're a direct cap table or nesting SPVs. And I think there's just a lot of lack of transparency. And it's going to be interesting, I guess, when OpenAI and Anthropic, you know, go public, and then we see some of the lawsuits or the misunderstandings of what people have thought. Misunderstandings, yes. They'll be like, oh, I'm locked up for 40 years. So I didn't realize I didn't see that. This is another thing. This is all I mean, and Jason, this this also speaks to something we talked about on last
58:56week's episode, which is just the broken public market. If you've I mean, these are the investors who should be investing in IPOs. And the fact that there are enough of them who want to be a part of these late stage private companies tells me those companies are ready to go public. Yes. And the investors are out there and they shouldn't have to pay 2%, 3% a year to get into the company. no access to information and exactly all right listen we got one more story i want to hit which is the anthropic uh preview but before we do that da before you tee that up i just want to give a shout out to my friends at athena.com slash jcal i was the first investor in this company the first investor in thumbttack, Jonathan's company and Marco's company, and they are
59:46crushing it. I have two full-time human EAs. Now, you say human EAs in the age of Grokbot and all these assistants and Instinct. Yeah, totally makes sense. Why would you have humans? I pair them with Grokbots. So they are making Grokbots. They're talking to Grokbots. I'm in the same threads with them. I have two of them seven days with them. I have two of them seven days a week. I have two Athena assistants seven days a week. They work 12 hours a day, essentially 10 to 12 hours a day. I have human coverage all the time, and they know how to use AI tools. So now I am absurdly, absurdly productive. I use it for domestic stuff. I do it for the business, and it works. For example, DA, I got bots who can find me all kinds of candidates,
1:00:31but LinkedIn doesn't let me write a personal email to them, so we're stuck, right? We have a blocker. So for now, we have a form letter from me that we send to 100 people a day who we're trying to hire in Austin, and it scales. And then they keep it in a database. It is wonderful. Go to athena.com slash jcal. You get $2,000 off. Highly recommend. Chamath has them too. All right. DA, tell us all about the anthropic IPO slash mythos slash humanity. Let me start. This is going to be a bit of a rant here. Okay, rant's allowed. I want to start with two video clips, and hopefully the team can pull them up. The first is, it's very self-serving. It's me. Okay. It's me, and I'm sorry to say it's me on another technology show last week.
1:01:21Totally. Can we roll this? This is very rough. There's a mix of naivete and sophistication among the AI folks. So when they hear AI people say smart things, they go, cool, yeah, let's run it. Sure, sure. Everyone respects Demis. Yeah, yeah. But when Demis says we're going to cure all diseases in 10 years, I think people who have two PhDs and have been doing this for 40 years go, come on, man. One, you're giving a sort of false hope to a lot of people who are legitimately out there suffering or have a loved one who's on death's doorstep. That's a little messed up. Okay. Yes. I love Crash Rack, too. And I got a lot of heat. Now, that answer was in response to being asked, basically, what do the old school big pharma people think of the AI gunslingers? So that was
1:02:08not necessarily my opinion. It kind of is my opinion, but I was trying to reflect what the big pharma old school drug discoverers in general sort of think about the claims of the AI innovators. And then within just a few days, and I got cooked for that online because people thought it was me saying I'm skeptical, which is like heresy. And then yesterday or the day before a video comes out from the Anthropic Roadshow of Dario saying the following. Look at things like cancer, Alzheimer's, heart disease, mental illness. These will be relics of the past in, I think, less than a decade. And I believe that the company which gets the risk right will also be the company that has the license to operate, that society trusts and society
1:03:02believes can build the benefits in the right way. So I think in Dario's comment, the saving grace is the phrase, I think, because it reveals that he's acknowledging that is his opinion. And by the way, he's welcome to have any opinions he wants. And I, in a sense, do think he's sincere. And I think he does believe a lot of things that I'm more skeptical of. And yet I hate being put in this position, whereas someone who's dedicated my career now for a decade to trying to fix our broken health care system, to trying to come up with cures for patients. I hate being put in the position of being a hater, sounding like a hater by being skeptical when Dario says all of these things that are afflicting your family and friends
1:03:59are gonna be gone in 10 years. And I just don't know what to do with that. It's like, it's very frustrating. Ben, what do you think here? What's your advice to DA who's obviously dealing with some cognitive dissonance here? He knows that it's CAP, right? We're going to have mental health in 20, we're going to have mental health issues in 2036. If what I saw on the internet this past week is any remote indicator, there's still a lot of mentally ill people out there. So how would you deal with this dissonance that he's dealing with? DA, I'm like, I'm vibing with all your stuff here. I, I, I, I feel the same way. And I think it extends beyond this specific topic of, you know, making healthcare promises, but just in general, the idea that there is this, like, get on the
1:04:53train and AI is going to save the whole world. And it's the greatest thing ever. And like, you'll all these deals, you should pay whatever they're worth. And it doesn't matter. And like, and anybody else is, you're like a relic and you don't know anything. And you're like, you know, you don't really get it. And I think that that is, that's happened in the market in general. Just this idea that like, get in the deepest part of the deep end or get out of the pool. And it bothers me too, because I'm a total optimist. I've literally committed my life to investing in like insane ideas before there's any evidence that they should even exist. And yet I sometimes feel like the pessimist in the room because of the way that everyone is sort of like behaving. It's frustrating. I think that talking about it. But don't you think you need to counter some of the doomerism that we have out there? And like, listen, I'm not advocating for
1:05:49not telling the truth, but like bringing glimmers of health, glimmers of hope in categories that matter like health. I do think it's important because the average person doesn't know this. They're just thinking data centers are sucking our water. But like, what about all the amazing things that are going to happen to our day-to-day experience with healthcare providers? But this is, this is politics though, because you have, you have, you're either a Trumper or a socialist. And it's like, and most people are like, I don't really want to be either of those things. What is going on here? Can't we- You just described my life for the last two years. Can't we live somewhere in here? And I think that you have,
1:06:25you know, DA that's like, I don't know which side that is, but it's like AI will cure all of our ills or data centers are evil and we should not. And like, we have to get out of the business entirely. And the answer is like, both these people are a little nuts. And in the middle here is like, how do you think it feels? I, and, and I don't mean to be grim here. How do you think it feels, and I don't mean to be grim here, how do you think it feels to be a late stage cancer patient and watch that video? And you've got this tech gunslinger telling you that, oh, you're just five years too early, bro. Sorry. You're just going to have to accept death because if I just had another five years, my company is going to fix all of
1:07:05this. DA, you are making a spectacular point. And two things can be true here. The Dumerists are lunatics. They don't know what they're talking about. They are suffering from delusions of grandeur. You remember when Han Solo came out of Carbonite and he says, I go to sleep for a little bit and then I wake up and everybody thinks they're a Jedi Knight. Like the Jedi have been gone for a long time. Like these people actually believe that they are the engineers and they're engineering the future of life. And to get like, you know, a little bit spiritual and religious here, the greatest sin you can have against God is to think that you're God. Like this is Adam and Eve, you know, and Satan saying like, well, you made babies,
1:07:51so therefore you're the gods now and you forsake God. These people are absolute lunatics who think that they have created God. They have been one-shotted, they one-shotted themselves. No matter how great this product is, it's software. Well, I just want to add one thing, which is we're investors, so this is native to us to think in probabilities and in scenarios. And unfortunately, nobody has a crystal ball, so that's the best you can do when it comes to forecasting. But Dario knows that. He's got a PhD, and he's a neuro guy, right? He's one-shotted. all statisticians who in their public communications have decided to give up on statistics. You know, why can't you just say, we think there's a 5% chance that we're going to cure
1:08:55all diseases in the next 10 years. And we think there's a 40% chance that this other middle of the road thing is going to happen. It's just all one or the other. It's delusion. And no, this group of people, this group of San Francisco people are literally been one-shotted. They have delusions of grandeur. They've seen into the black magic, guess the next word box. And they literally believe it will be recursive, solve every problem in the world. And there is evidence that every math problem is going to get solved. But you're right, DA, it's not going to reverse dad's prostate cancer or mom's Alzheimer's. Well, I hope it does. And we're going to try. We're going to use all of it. But my question for this group is, what probability does each of you put on the ultimate accelerationist view, on basically
1:09:47on the Dario view? I mean, we should acknowledge there's a chance that could happen. And that's what part of what makes us all excited. To find what that is. Super intelligence solves all disease. We live forever. We get RSI in the next couple of years. It solves everything. There's no Microsoft anymore because Claude Tools that they put a video out on yesterday just makes everything obsolete. The whole pharmaceutical industry becomes obsolete. Venture capital, everything, just everything is different. You should put all your money in Anthropic. Why do anything else? And what probability do we put on that? Well, it's not P Doom. It's P Paradise. What's your P Paradise? I think there's Utopia, P Utopia.
1:10:26Extraordinarily low likelihood of this. I don't know how low, but I'm not- Low single digits? Under 1%? Lower than low single digits. Basis points. Okay, your P Utopia is, I'm going to put it at 10 bips. I'm a little more positive on that. Yeah, I think you may. You're positive on the end of society? No, on the are we going to solve these problems in the way the problem is articulated. Jason, you sort of pulled the thread a bit there. So there's a difference between are we going to get good advancements in medicine or are we like is Anthropic the final company? As stated by DA da every problem in the world is solved humanity has no disease all problems are solved in the next basically just what dario said in 10 years we solve all diseases all diseases mental health alzheimer's in under 10
1:11:19years percentage chance of that zero zero okay i'm with you i'm with you. I'm at P-001. Well, I'll take the over on that. I mean, listen, cancer is hundreds of diseases. And so is heart disease and mental illness and, you know, discovery speed up doesn't make them all vanish. So as Dario stated, as Dario stated, you're P-1, P-Dario-1, PD-1, PD-2? I'm going to, yeah. I mean, I am hopeful that this is going to happen. In under 10 years. There's a timeline associated with this. DA, where do you put it? What is your Pdario? 10 years, all diseases are cured. He believes it. Yeah, I think my Pdario is between 1% and 5%. Really? I'll take that. And I'll tell you why. Because if you told me tomorrow, you're president of the United States, you need to assemble the cabinet.
1:12:21I'd go and I'd try to find the smartest people I could possibly find in every area. And Dario would probably be one of those people. Even if you just said you need the AI cabinet. Of course, you get Dario, you get Zuck, you get Larry Page. I mean, don't forget, Zuck and Priscilla's philanthropy made the same promise. I don't know what it was eight, ten years ago then, right? We're going to start Chan Zuckerberg initiative and we're going to solve all disease. And they've been doing amazing work. They haven't solved all disease, but they've done a lot of really cool molecular biology work and virtual cell work. I think if you talk to Larry and Sergey, they probably believe something kind of similar.
1:13:25So the, and you go talk to Elon, he believes something kind of similar. So go talk to Elon. He believes something kind of similar. So it's not that I, as the feeble investor, am there intellectually, but I have to put some weight on the smartest technologists that are on the planet today agreeing with this view. So I don't know how much I put on that, but that's why I say somewhere between 1% and 5%. Okay. Another amazing episode. Now at the end of the episode, we always like to go around the horn, and everybody gets to give a little shine, and you get to double down, Ben. You got your recent- I wasn't trying earlier. I apologize. No, a little double down's okay. DA's playing his best of clips from around the web.
1:13:48He's going to double dip as well. DA, start with you. Tell us about a company that you're excited about that you placed a bet on. You placing a bet is a big- Yeah, well, really cool company. They actually based down there in Texas where you are, J Cal and it's called Phantom Neuro. We invested in this company a few years ago and what they've developed is an implantable device that can go right under a patient's skin and above their muscle. And what this can enable is folks who have had an upper limb amputation. Imagine you've lost your arm from the elbow down. You can get this implant right here in the amputation stump, and it can detect the nerve signals that you're sending from your brain to the forearm and hand that you no longer have.
1:14:36And thereby you can control a robotic prosthetic limb just by thinking about it. Now, obviously, we're also investors in Neuralink. We love the BCI vision as well, but this is something that can be done in an outpatient, minimally invasive procedure in less than an hour. And why I'm so excited about this is because they just finally, a few months ago, implanted the first patients in a study in Australia. And it's just remarkable when you do this kind of stuff to finally see the video of someone getting it and controlling a prosthetic limb effortlessly. And so that's what makes this worth doing and keeps you going. And I was just super juiced about that. It's incredible. And the total addressable market for this has to be millions of people, right?
1:15:29There's millions of people. There are a lot of amputees. And unfortunately, a lot of those amputees are veterans. And when you've got conflicts like the one in Ukraine today, it's just shocking how many folks come out of those episodes without an arm or a leg and basically only have Civil War era technology to, you know, Civil War era technology. is because that is basically the best thing that's out there. And the issue has not been a lack of robotics, because robotic hands have gotten really cool, but it's the ability to control them. Ben, what do you got? That is so cool. This makes me happy. That's a cool company. It's good to be an venture capitalist. How early did you invest in that, DA?
1:16:21We were a seed investor about three years ago. That's really, really awesome. I'm going to do something that is probably not going to save the world, but it's a company I think is really cool in that- It's not the Mets, is it? I wish it was the Mets. Go to launchpointhq.com. Launchpoint. Launchpoint HQ. talk, um, with the same sort of targeting with, uh, where you could turn on real scale with UGC. And, uh, I won't get ahead of myself, but the, the poll is pretty insane on this one. And, um, the, basically the short version is, um, it works and it really works. And if you're a brand, if you're a company who's trying to attract a bunch of new customers, there is a new channel to spend money at scale that is
1:17:35performant like Facebook or Google or Insta. And there's really, you go back to sort of like the trade desk many years ago, maybe more recently in Applovin, it's very rare that you find a real scaled platform to go and do performance marketing. And this is the first thing I've seen that looks like that. And if you look at the customers who are spending, you got your micro one folks up there. I saw that. It is brands that have real need to grow quickly and big budgets and real sophistication are leaning in hard. So I think it's an amazing company. And these people all label it. Hey, I'm doing a shout out for Micro One. Here's what they do. It's they're making a little bit of money in this influencer. from people who were not professional drivers and, and, and found a way to make a living.
1:18:46And there are a very rapidly enlarged group of folks who are making a living doing this now because of love. Brilliant. Jenny, what do you got? What do you got? Well, I already gave my pitch today on jelly. So the last thing I'll say on that is, um, if you're an emerging manager or you have, I use jelly. I want to use jelly. Yeah, why don't you just all send me. You're in the chat. Yeah, D-A is on the, yeah. And we'll get you Jason, Ben. And like if you're a professor and you want to give this to your students, like we have lots of good use cases. So just on the website, you can sign up or just message me, jateverywhere.vc, and we'll get you signed up on the beta and then launched later this year.
1:19:25So that's it. I'll give a shout out for a company we incubated, Obliteration dot AI. You probably have heard about obliterated models. They're able to do anything. They have all of the safety and guardrails off of them. Well, why would you invest in that? Well, it turns out when new models come out, people who are trying to do cybersecurity and, you know, you got to be vetted to use this product. You're not allowed to use the new fable. You have to wait until your system has been hacked already. So if you're doing red teaming, et cetera, you can use obliteration AI to use things like GLM 5.3, et cetera. And then it's up to you to build up the harness and the controls. And so this is really transformative in giving the good guys and gals, CSOs and their
1:20:16teams, the ability to see what these models can do without the guardrails on them in order to find all the leaks in their cyber security. So I'm really excited about this one. They went to launch and then they went to speed run, A16. We've had like, I don't know, 10 companies go from R Accelerator to speed run now. And Dreesenhart, speaking about platforms, being incredibly aggressive with speed run. They will very quickly review your startups, Jenny, if you wanted to have them go get that experience. They're very fast. I think they're really sticking it to Y Combinator a bit, creating a bit of a competitor, I will say. Founders are really evaluating them alongside YC. All right, another amazing episode.
1:21:06DA, thank you. Ben. Well done. Jenny, of course, knocked it out of the park and we'll see you all next time. Bye-bye.

